Woman writing math equation on white board

FDA · EU MDR · Health Canada

Regulatory strategy for SaMD, AI/ML and medical devices

A clear pathway from first questions to clearance, and a plan for the changes that come after it.

Talk to Cosm
Woman writing math equation on white board
U.S., EU, Canada and more

One regulatory strategy for FDA, the EU and Health Canada, with other markets added as you need them.

01

Strategy and device determination

Whether your product is a device, its classification, the right pathway and the evidence a reviewer will expect. Includes Breakthrough Device designation requests when your technology qualifies.

02

Pre-Submissions

Questions FDA can answer, a package that supports them, and a plan to use the feedback to reduce avoidable review questions later.

What is an FDA Pre-Sub? →
03

510k, De Novo and EU MDR submissions

Planning, writing and submitting, including the software, cybersecurity and human factors sections reviewers look at closely.

04

Changes after clearance

Deciding when a change needs a new 510k, documenting the ones that do not, and Predetermined Change Control Plans (PCCPs) for planned AI/ML updates.

PCCP guide →
05

Clinical evaluation and post‑market

We prepare CEPs, CERs, PMCF plans and reports, PMS reports, PSURs and SSCPs for medical device software and AI, and run literature and safety searches. We agree the scope, fee and schedule for each project, with no recurring retainer or monthly minimum.

Clinical evaluation →
Laptop that says FDA GuidanceVR headsetDesktop showing brain scansApple watch
Regulatory strategy

Regulatory Roadmap for Medical Devices

Timing depends on your device, the pathway and the evidence you already have.

Device determination

Device status, classification and pathway.

A written plan your team can follow.

1 to 3 weeks

Pre-Submission

Questions and a package FDA can answer.

Written feedback, and a meeting if you ask for one.

about 70 days

Evidence plan

Testing, software, cybersecurity and human factors, scoped to the pathway.

varies

Submission

510k, De Novo or EU technical documentation, assembled and submitted.

4 to 8 weeks

Review and beyond

Answers to reviewer questions, then change control and PCCPs.

No recurring retainer or monthly minimum.

as needed
AI/ML SaMD

AI-enabled device software

FDA guidance now covers how AI-enabled device software should be described, tested and changed over time, including Predetermined Change Control Plans (PCCPs).

We help you plan model changes up front, write the PCCP, and document data management, performance testing and transparency the way reviewers look for them.

AI/ML SaMD topic page →
Device or not

General wellness, CDS and other gray areas

Wearables, wellness apps and clinical decision support software can sit close to the line between a consumer product and a medical device. Small wording changes can move a product across it.

We help you decide where your product sits, word your claims to match, and plan for the point where a device pathway makes sense.

Security

Cybersecurity

For cyber devices, section 524B of the FD&C Act requires an SBOM, a plan for postmarket vulnerabilities and evidence of secure design.

FDA's premarket cybersecurity guidance sets out what the submission should contain. We help you build that file alongside development, not at the end.

Threat modeling
  • Architecture views
  • Threat model at the level reviewers expect
SBOM and vulnerabilities
  • Machine-readable SBOM
  • Vulnerability assessment and support plans
Security risk management
  • Linked to your safety risk file
  • Traced to design controls
Testing and postmarket
  • Penetration testing scope and reports
  • Postmarket vulnerability management plan
Know your way forward.

Planning a submission or not sure which pathway fits?

Talk it through with Cosm.

Talk to Cosm